AKT1 and rheumatoid arthritis: Thus, we further administrated the PI3K inhibitor, wortmannin (1 μM) and Akt inhibitor VIII (10 μM) to explore whether RA protects AR injury through the PI3K/Akt signaling pathway, which was consistent with previous research (Xu et al., 2008; Liu et al., 2020).